FREE Account Opening + No Clearing Fees
Loading...

Emcure Pharma IPO vs Veranda Learning IPO

Comparision between Emcure Pharma IPO and Veranda Learning IPO.

IPO Details

Emcure Pharma IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Veranda Learning IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

  Emcure Pharma IPO Veranda Learning IPO
Logo Emcure Pharma IPO Logo Veranda Learning IPO Logo
Issue Category Mainline Mainline
Issue Type IPO IPO
Process Type Book Built Issue Book Built Issue
Listing At BSE, NSE BSE, NSE
Lead Managers Kotak Mahindra Capital Company Limited

Axis Capital Limited

Jefferies India Private Limited

J.P. Morgan India Private Limited
Systematix Corporate Services Limited
Registrar Link Intime India Private Ltd Kfin Technologies Limited
Market Maker
DRHP DRHP DRHP
RHP RHP
Anchor Investor
IPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of Emcure Pharma IPO is whereas the issue size of the Veranda Learning IPO is up to ₹200.00 Cr. The final issue price of Emcure Pharma IPO is and of Veranda Learning IPO is ₹137.00 per share.

  Emcure Pharma IPO Veranda Learning IPO
Face Value ₹10 per share ₹10 per share
Issue Price (Lower) ₹130.00 per share
Issue Price (Upper) ₹137.00 per share
Issue Price (Final) ₹137.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 100 shares
Fresh Issue Size
Fresh Issue Size (Amount) up to ₹800.00 Cr up to ₹200.00 Cr
OFS Issue Size 1,36,78,839 shares
OFS Issue Size (Amount)
Issue Size Total
Issue Size Total (Amount) up to ₹200.00 Cr

IPO Timetable

Emcure Pharma IPO opens on , while Veranda Learning IPO opens on Mar 29, 2022. The closing date of Emcure Pharma IPO and Veranda Learning IPO is , and Mar 31, 2022, respectively.

  Emcure Pharma IPO Veranda Learning IPO
Anchor Bid Date
Issue Open Mar 29, 2022
Issue Close Mar 31, 2022
Basis Of Allotment (Tentative) Apr 05, 2022
Initiation of Refunds (Tentative) Apr 06, 2022
Credit of Share (Tentative) Apr 06, 2022
Listing date (Tentative) Apr 11, 2022
Anchor Lockin End date 1 May 05, 2022
Anchor Lockin End date 2 Jul 04, 2022

Financials

Emcure Pharma IPO P/E ratio is , as compared to Veranda Learning IPO P/E ratio of .

  Emcure Pharma IPO Veranda Learning IPO
Financial
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (₹ in Millions)
  31-March-21 31-March-20 31-March-19
Total Assets 68,073.98 60,040.55 58,104.39
Total Revenue 60,918.06 51,308.60 48,155.90
Profit After Tax 4,185.94 1,006.10 2,029.68
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (Rs in Millions)
  30-Sep-21 31-Mar-21
Total Assets 3,073.65 115.19
Total Revenue 156.61 25.45
Profit After Tax (182.69) (82.79)
Promoter Shareholding (Pre-Issue) 89.22%
Promoter Shareholding (Post-Issue) 65.87%
P/E Ratio
Market Cap ₹764.12 Cr.
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Emcure Pharma IPO retail investors (RII) are offered while in Veranda Learning IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Emcure Pharma IPO and 43,79,562 shares in Veranda Learning IPO.

  Emcure Pharma IPO Veranda Learning IPO
Anchor Investor Reserveration 65,69,343 shares
Market Maker Reserveration
QIB 43,79,562 shares
NII 21,89,781 shares
RII 14,59,854 shares
Employee
Others
Total 1,45,98,540 shares

Bids Received (Subscription)

Emcure Pharma IPO subscribed in total, whereas Veranda Learning IPO subscribed 3.53x.

  Emcure Pharma IPO Veranda Learning IPO
QIB (times) 2.02x
NII (times) 3.87x
Big NII (times)
Small NII (times)
RII (times) 10.76x
Employee (times)
Other (times)
Total (times) 3.53x

Comments

Add a public comment...